Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Sep 11, 2020
Date Accepted: Nov 30, 2020
Date Submitted to PubMed: Dec 2, 2020

The final, peer-reviewed published version of this preprint can be found here:

Smartphone-Based Virtual Agents to Help Individuals With Sleep Concerns During COVID-19 Confinement: Feasibility Study

Philip P, Dupuy L, Morin CM, de Sevin E, Bioulac S, Taillard J, Serre F, Auriacombe M, Micoulaud-Franchi JA

Smartphone-Based Virtual Agents to Help Individuals With Sleep Concerns During COVID-19 Confinement: Feasibility Study

J Med Internet Res 2020;22(12):e24268

DOI: 10.2196/24268

PMID: 33264099

PMCID: 7752183

Smartphone-Based Virtual Agents to Help the General Population Concerned by Sleep Complaints During COVID-19 Confinement: A Feasibility Study

  • Pierre Philip; 
  • Lucile Dupuy; 
  • Charles M. Morin; 
  • Etienne de Sevin; 
  • Stéphanie Bioulac; 
  • Jacques Taillard; 
  • Fuschia Serre; 
  • Marc Auriacombe; 
  • Jean-Arthur Micoulaud-Franchi

ABSTRACT

Background:

The COVID-19 crisis induces psychosocial stress and sleep complaints that require early management. KANOPEE is a smartphone-based application, providing an interaction with a virtual agent dedicated to screen and deliver behavioral interventions to fight sleep disorders.

Objective:

This paper describes the feasibility study of this application, during the context of COVID-19 confinement in France.

Methods:

2,069 users of aged 18 years and over downloaded the app during the inclusion period (between 22 April and 5 May 2020). Users first answered a screening interview based on the Insomnia Severity Index (ISI) that was conducted by the virtual agent. If participants were positive for insomniac complaints (ISI > 14), they could join a two-stage intervention program: a) complete an electronic sleep diary for one week, and b) follow personalized sleep recommendations for 10 days. Measures collected included socio-demographic information, ISI and sleep/wake schedules; and acceptance and trust of the agent.

Results:

Of all participants, 80% (n=1,574) completed the screening interview with the virtual agent. The virtual agent was well accepted by users regarding its usability, satisfaction, benevolence, and credibility. Of the 773 screened subjects who reported sleep complaints (ISI>14), 214 of them followed the first step of the intervention (34%). Of these, 47 (31%) followed the second step. Users who completed step one found that their insomnia complaints (mean scores: baseline ISI: 18.56; ISI after step one: 15.99; P<.001) and nocturnal sleep improved significantly after one week. Subjects who completed step 2 also showed an improvement compared to the initial measure (mean scores: baseline ISI: 18.87; ISI after step two: 14.68; P<.001). The most severely affected subjects (ISI >21) did not respond to either intervention.

Conclusions:

These preliminary results show that KANOPEE is a promising solution to screen populations for sleep complaints, and that it provides practical and effective behavioral advice for subjects reporting moderately severe insomnia.


 Citation

Please cite as:

Philip P, Dupuy L, Morin CM, de Sevin E, Bioulac S, Taillard J, Serre F, Auriacombe M, Micoulaud-Franchi JA

Smartphone-Based Virtual Agents to Help Individuals With Sleep Concerns During COVID-19 Confinement: Feasibility Study

J Med Internet Res 2020;22(12):e24268

DOI: 10.2196/24268

PMID: 33264099

PMCID: 7752183

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement